Restech’s pH system was the highlight of new research presented by Dr. Ezra Teitelbaum at the 2017 American College of Surgeons’ Clinical Congress that took place at the San Diego Convention Center last weekend. Dr. Teitelbaum (Assistant Professor of Surgery and Medical Education at Northwestern University) collaborated with Dr. Steven DeMeester (President and Executive Director of the Foundation for Research and Education in Esophageal and Foregut Disorders) in his research on the Comparison of Simultaneous Pharyngeal and Distal Esophageal pH Monitoring Studies.
In his presentation, Novel Endoscopic and Minimally Invasive Techniques for Esophageal Dysmotility and Reflux Disease, he compared the results of different pH monitoring tests in patients off antisecretory medications.
While there was a 94% agreement between abnormal and normal studies in the Bravo and Restech pH systems, the low agreement between the esophageal catheter pH monitoring system and Bravo suggests that the esophageal catheter pH monitoring system produces low sensitivity in patients with extraesophageal symptoms.
The Restech test possesses advantages over Bravo because it does not require invasive manometry or endoscopy for placement. With greater patient comfort, minimally invasive in-office placement, and excellent specificity/sensitivity, Restech pharyngeal pH monitoring is suggested as a first line test for use in patients with extraesophageal symptoms.
“In conclusion based on these results, our current recommendation is that in the evaluation of patients with extraesophageal symptoms, they undergo either a Bravo or a Restech for assessment of those symptoms in an effort to link GERD as a causal agent... [Restech] could potentially facilitate easier objective evaluation of reflux, while decreasing patient discomfort and risk of undergoing those associated procedures.” - Dr. Ezra Teitelbaum
Restech develops and markets transformative diagnostic technologies to accurately diagnose and better manage reflux. Restech’s patented technology is employed throughout the US and globally, providing greater patient comfort, simple in-office placement, and highly accurate results. These unique diagnostic tools are helping to evolve the standard of care for patients with reflux, providing physicians with the necessary data to transform the algorithm of care for millions of patients.
For more information on the Dx-pH Measurement System, please Call 800.352.1512 or visit www.restech.com.